Presidio Management Group X LLC
CIK 0001602744 Name as filed on the most recent filing
Filed as Presidio Management Group X LLC (16)
80 transaction lines · from 16 filings · filed 2020-05-27 to 2022-08-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2021-11-29 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 24,965 disposed | 6.70 | 167,140.68 | Form 4, filing 0001062993-21-011920 | |
| 2021-11-29 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 799 disposed | 6.70 | 5,349.30 | Form 4, filing 0001062993-21-011920 | |
| 2021-11-26 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 4,870 disposed | 7.01 | 34,148.44 | Form 4, filing 0001062993-21-011704 | |
| 2021-11-26 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 156 disposed | 7.01 | 1,093.25 | Form 4, filing 0001062993-21-011704 | |
| 2021-11-24 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 35,388 disposed | 7.36 | 260,278.74 | Form 4, filing 0001062993-21-011704 | |
| 2021-11-24 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 1,132 disposed | 7.36 | 8,325.86 | Form 4, filing 0001062993-21-011704 | |
| 2021-11-23 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 14,418 disposed | 7.40 | 106,736.45 | Form 4, filing 0001062993-21-011704 | |
| 2021-11-23 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 461 disposed | 7.40 | 3,413.24 | Form 4, filing 0001062993-21-011704 | |
| 2021-11-22 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 25,371 disposed | 7.86 | 199,416.06 | Form 4, filing 0001062993-21-011394 | |
| 2021-11-22 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 812 disposed | 7.86 | 6,382.32 | Form 4, filing 0001062993-21-011394 | |
| 2021-11-19 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 7,017 disposed | 8.12 | 56,985.06 | Form 4, filing 0001062993-21-011394 | |
| 2021-11-19 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 224 disposed | 8.12 | 1,818.88 | Form 4, filing 0001062993-21-011394 | |
| 2021-11-18 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 16,226 disposed | 8.53 | 138,375.33 | Form 4, filing 0001062993-21-011394 | |
| 2021-11-18 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 519 disposed | 8.53 | 4,426.03 | Form 4, filing 0001062993-21-011394 | |
| 2021-11-17 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 9,918 disposed | 9.13 | 90,521.59 | Form 4, filing 0001062993-21-011097 | |
| 2021-11-17 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 317 disposed | 9.13 | 2,893.58 | Form 4, filing 0001062993-21-011097 | |
| 2021-11-16 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 8,062 disposed | 9.42 | 75,935.98 | Form 4, filing 0001062993-21-011097 | |
| 2021-11-16 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 257 disposed | 9.42 | 2,420.94 | Form 4, filing 0001062993-21-011097 | |
| 2021-11-15 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 4,914 disposed | 9.81 | 48,211.25 | Form 4, filing 0001062993-21-011097 | |
| 2021-11-15 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 157 disposed | 9.81 | 1,540.01 | Form 4, filing 0001062993-21-011097 | |
| 2021-11-12 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 11,628 disposed | 10.07 | 117,093.96 | Form 4, filing 0001062993-21-010758 | |
| 2021-11-12 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 372 disposed | 10.07 | 3,746.04 | Form 4, filing 0001062993-21-010758 | |
| 2021-11-11 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 11,644 disposed | 10.37 | 120,724.99 | Form 4, filing 0001062993-21-010758 | |
| 2021-11-11 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 373 disposed | 10.37 | 3,867.26 | Form 4, filing 0001062993-21-010758 | |
| 2021-11-10 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 32,946 disposed | 10.44 | 343,824.46 | Form 4, filing 0001062993-21-010758 | |
| 2021-11-10 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 1,054 disposed | 10.44 | 10,999.54 | Form 4, filing 0001062993-21-010758 | |
| 2021-11-09 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 27,892 disposed | 11.00 | 306,923.57 | Form 4, filing 0001062993-21-010758 | |
| 2021-11-09 |
eFFECTOR Therapeutics, Inc. EFTR |
S, Open-market sale | 893 disposed | 11.00 | 9,826.57 | Form 4, filing 0001062993-21-010758 | |
| 2020-11-18 |
Inari Medical, Inc. NARI |
S, Open-market sale | 20,000 disposed | 66.38 | 1,327,600.00 | Form 4, filing 0001527715-20-000024 | |
| 2020-05-27 |
Inari Medical, Inc. NARI |
P, Open-market purchase | 97,962 acquired | 19.00 | 1,861,278.00 | Form 4, filing 0001548538-20-000010 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Presidio Management Group X LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001602744
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6